SCHEMBL7497652

SCHEMBL7497652

Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 1.00
ABL1 P00519 5/20 1.00
ABL2 P42684 2/20 1.00
ERBB2 P04626 2/20 0.65
PTK6 Q13882 1/20 0.65
BRAF P15056 1/20 0.63
TNNI3K Q59H18 1/20 0.63
FADS1 O60427 2/20 0.61
LCK P06239 1/20 0.60
TTBK1 Q5TCY1 1/20 0.59
TTBK2 Q6IQ55 1/20 0.59
PRKCA P17252 3/20 0.55
SRC P12931 2/20 0.55
PDGFRB P09619 1/20 0.55
PDGFRA P16234 1/20 0.55
CDK1 P06493 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7499723 0.99 EGFR (0.97) EGFRABL1ABL2ERBB2PTK6
SCHEMBL7497212 0.85 EGFR (0.73) EGFRABL1ABL2ERBB2PTK6
SCHEMBL7216425 0.84 EGFR (1.00) EGFRABL1ABL2ERBB2BRAF
SCHEMBL7222290 0.84 EGFR (1.00) EGFRABL1ABL2BRAFTNNI3K
Hydrochloric Acid SCHEMBL7217999 0.83 EGFR (0.97) EGFRABL1ABL2BRAFTNNI3K
SCHEMBL27199972 0.81 EGFR (0.68) EGFRABL1ABL2ERBB2PTK6
SCHEMBL29406611 0.79 EGFR (1.00) EGFRABL1ABL2PRKCA
SCHEMBL2463632 0.79 EGFR (1.00) EGFRABL1ABL2PRKCA
SCHEMBL2462851 0.78 EGFR (1.00) EGFRABL1ABL2FADS1TTBK1
SCHEMBL6882539 0.77 TNNI3K (1.00) EGFRABL1ABL2BRAFTNNI3K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836605-B1 PYRROLOPYRIMIDINES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2002-02-06 EP disclosed
US-6140332-A Pyrrolopyrimidines and processes for the preparation thereof NOVARTIS AG (CH) 2000-10-31 US disclosed
EP-0836605-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1998-04-22 EP disclosed
WO-1997002266-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1997-01-23 WO disclosed